Psychodynamic, CBT Show Long-Term Efficacy for SAD
the Psychiatry Advisor take:
Just how effective is psychotherapy in treating social anxiety disorder (SAD)? German researchers have recently discovered that cognitive-behavioral therapy (CBT) and psychodynamic therapy were useful in treating SAD, in both the short- and long-term.
Response rates to both treatments were about 70% by the end of a two-year follow-up, and remission rates were about 40%, Falk Leichsenring, DSc, of the Clinic of Psychosomatics and Psychotherapy at the Justus-Liebig University in Giessen, Germany, and colleagues reported in the American Journal of Psychiatry.
A prior study examined CBT, psychodynamic therapy, and a control group, but the purpose of the new study was the follow the patients’ progress over 24 months.
“Although in the short-term, intention-to-treat analyses yielded some statistically significant but small differences in favor of CBT in several outcome measures, no differences in outcome were found in the long-term,” the researchers wrote.
Psychodynamic and Cognitive-Behaviorial Therapy in Treating SAD
Psychiatry Advisor Articles
- Family History of Psychiatric Disorders an Important Predictor of Postpartum Psychiatric Illness
- New APA President Takes Office as the First African-American to Lead the Organization
- MDMA-Assisted Psychotherapy Effective for Treating PTSD in Veterans, First Responders
- Antidepressant Use May Be Linked With Sustained Risk for Weight Gain
- Early Intervention Services Superior to Treatment as Usual for Early-Phase Psychosis
- Video Games and Exercise as Alternative Therapies for ADHD
- How Parents Can Enhance Autism Treatment: Use of Intervention Strategies at Home
- Electroconvulsive Therapy Effective in Children With Autism
- The Cutting Edge of Schizophrenia Research: VR as Treatment for Psychosis
- Cannabidiol Not Associated With Improvement in Chronic Schizophrenia
- New Dimensions in Psychopathy: Are There Cultural Differences in Psychopaths?
- Addressing Psychiatric Comorbidities in Inflammatory Rheumatic Diseases
- Exploring the Link Between Persistent Infection, Inflammation, and Mood Disorders
- CDC: No Change in Level of Uninsured in US in 2017
- Benefit of Behavioral Activation During TMS for Major Depressive Disorder